Dermatomyositis associated with ovarian transitional cell carcinoma.
Hagman
J H
JH
Bianchi
L
L
Campione
E
E
Vidolin
A P
AP
Chimenti
S
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000150:complications* / Q000473:pathology / Q000601:surgery; D003882:Dermatomyositis / Q000209:etiology* / Q000473:pathology; D004487:Edema / Q000209:etiology; D005143:Eyelids / Q000473:pathology; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D008875:Middle Aged; D018908:Muscle Weakness / Q000209:etiology; D018482:Muscle, Skeletal / Q000473:pathology; D009362:Neoplasm Metastasis; D009852:Omentum / Q000473:pathology; D010051:Ovarian Neoplasms / Q000150:complications* / Q000473:pathology / Q000601:surgery
D016756:Immunoglobulins, Intravenous